Your breakthrough therapies deserve the support of a CMO as committed as you are. Together, we’ll help make your sterile injectable therapies reliable and patient-friendly.
As developers offer an increasing number of complex therapeutics and drug delivery systems, manufacturers must evolve to meet customer needs while safely and efficiently delivering treatments.
Our network currently spans across nine manufacturing sites in five countries and can support discovery, preclinical, clinical, and commercial programs for New Chemical Entities (NCEs).
Through a science-led approach and extensive experience, our team can support you with aseptic and terminally sterilized small-volume liquids, as well as lyophilized and spray-dried powders.
Oval’s proprietary primary drug containers offer a wide range of benefits over traditional glass-based systems. The use of cyclic olefin copolymer (COC) allows for much greater design flexibility.
With a wide range of technologies at its disposal, we can provide comprehensive services in this rapidly evolving field, catering to the unique needs and requirements of its clients.
By partnering with us, you gain access to our unique, interconnected network, purpose-built to overcome the breakpoints common in traditional manufacturing models.
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
